Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MEDIRAD

Financiado

Implications of Medical Low Dose Radiation Exposure

MEDIRAD aims to enhance the scientific bases and clinical practice of radiation protection (RP) in the medical field and thereby addresses the need to understand and evaluate the health effects of low dose ionising radiation expos... ver más

28/02/2022

EIBIR GEMEINNUTZIG...

10M€

Presupuesto del proyecto: 10M€

Líder del proyecto

EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 34 Participantes

Financiación concedida El organismo FP6 notifico la concesión del proyecto el día 2022-02-28

NFRP-3: Investigating the safety of closed...

I+D

Cerrada hace 8 años

0% 100%

34 Participantes

EIBIR GEMEINNUTZIGE GMBH ZUR...

Lider

ICS

N.D. | Participante

INSTITUT CATALA D'ONCOLOGIA

N.D. | Participante

FUNDACION PRIVADA INSTITUTO...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

HARMONIC Health effects of cArdiac fluoRoscopy and MOderN radIotherap... 7M€ Cerrado

PID2019-110369RB-I00 HORMESIS INDUCIDA POR RADIACION EN ONCOLOGIA 165K€ Cerrado

iMPACT innovative Medical Protons Achromatic Calorimeter and Tracke... 2M€ Cerrado

PGC2018-101302-B-I00 DESARROLLO DE DOSIMETRIA DE PRECISION EN RADIOTERAPIA 41K€ Cerrado

SAF2009-10485 RIESGO RADIOLOGICO EN PROCEDIMIENTOS INTERVENCIONISTAS (GUIA... 62K€ Cerrado

DPI2016-79075-R NUEVOS ESCENARIOS DE TOMOGRAFIA POR RAYOX X 148K€ Cerrado

Duración del proyecto: 56 meses Fecha Inicio: 2017-06-01
Fecha Fin: 2022-02-28

Líder del proyecto

EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 10M€

Descripción del proyecto MEDIRAD aims to enhance the scientific bases and clinical practice of radiation protection (RP) in the medical field and thereby addresses the need to understand and evaluate the health effects of low dose ionising radiation exposure from diagnostic and therapeutic imaging and from off-target effects in radiotherapy (RT).MEDIRAD will pursue 3 major operational objectives: First, it will improve organ dose estimation and registration to inform clinical practice, optimise doses, set recommendations and provide adequate dosimetry for clinical-epidemiological studies of effects of medical radiation. Second, it aims to evaluate and understand the effects of medical exposures, focusing on the two major endpoints of public health relevance: cardiovascular effects of low to moderate doses of radiation from RT in breast cancer treatment incl. understanding of mechanisms; and long-term effects on cancer risk of low doses from CT in children. Third, it will develop science-based consensus policy recommendations for the effective protection of patients, workers and the general public. Within the 4-year project a multi-disciplinary consortium will, in close interaction with European medical associations, MELODI and EURADOS (1), develop a tool to determine image quality to maximise optimisation of RP in medical imaging, (2) improve and develop new individual organ/anatomical structure dosimetry from chest CT, I131 administration, fluoroscopy-guided procedures, hybrid imaging, and RT for breast cancer and interlinks with image quality measures, (3) conduct epidemiological studies of consequences of RT and CT, (4) identify potential novel imaging and circulating biomarkers and mechanisms of radiation effects, (5) develop innovative risk models, (6) develop and implement for the first time a European repository of patient dose and imaging data, (7) develop science-based recommendations, and (8) introduce novel approaches to bring together the nuclear and medical sectors.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores